Aptorum Group LimitedAptorum Group LimitedAptorum Group Limited

Aptorum Group Limited

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.83 M‬USD
‪−2.82 M‬USD
‪431.38 K‬USD
‪2.17 M‬
Beta (1Y)
−0.12
Employees (FY)
3
Change (1Y)
−16 −84.21%
Revenue / Employee (1Y)
‪143.79 K‬USD
Net income / Employee (1Y)
‪−941.55 K‬USD

About Aptorum Group Limited


CEO
Ian Huen
Headquarters
London
Founded
2010
FIGI
BBG00LX0JFQ4
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of APM is 0.7399 USD — it has increased by 0.09% in the past 24 hours. Watch Aptorum Group Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aptorum Group Limited stocks are traded under the ticker APM.
APM stock has risen by 0.90% compared to the previous week, the month change is a −5.95% fall, over the last year Aptorum Group Limited has showed a −65.10% decrease.
APM reached its all-time high on Jun 4, 2019 with the price of 332.8000 USD, and its all-time low was 0.4600 USD and was reached on Nov 18, 2024. View more price dynamics on APM chart.
See other stocks reaching their highest and lowest prices.
APM stock is 7.96% volatile and has beta coefficient of −0.12. Track Aptorum Group Limited stock price on the chart and check out the list of the most volatile stocks — is Aptorum Group Limited there?
Today Aptorum Group Limited has the market capitalization of ‪3.50 M‬, it has decreased by −2.24% over the last week.
Yes, you can track Aptorum Group Limited financials in yearly and quarterly reports right on TradingView.
Aptorum Group Limited is going to release the next earnings report on Apr 21, 2025. Keep track of upcoming events with our Earnings Calendar.
No, APM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 3.00 employees. See our rating of the largest employees — is Aptorum Group Limited on this list?
Like other stocks, APM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aptorum Group Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aptorum Group Limited technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aptorum Group Limited stock shows the sell signal. See more of Aptorum Group Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.